Inicio>>Signaling Pathways>> Endocrinology and Hormones>> Androgen Receptor>>GLPG0492 R enantiomer

GLPG0492 R enantiomer

Catalog No.GC30101

El enantiómero GLPG0492 R es el enantiómero R de GLPG-0492, que es un nuevo modulador selectivo del receptor de andrógenos.

Products are for research use only. Not for human use. We do not sell to patients.

GLPG0492 R enantiomer Chemical Structure

Cas No.: 1215085-93-0

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
276,00 $
Disponible
2mg
214,00 $
Disponible
5mg
321,00 $
Disponible
10mg
459,00 $
Disponible
50mg
1.379,00 $
Disponible
100mg
1.930,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

GLPG0492 R enantiomer is the R enantiomer of GLPG-0492, which is a novel selective androgen receptor modulator.

[1]. Nique F, et al. Identification of a 4-(hydroxymethyl)diarylhydantoin as a selective androgen receptor modulator. J Med Chem. 2012 Oct 11;55(19):8236-47. [2]. Cozzoli A, et al. GLPG0492, a novel selective androgen receptor modulator, improves muscle performance in the exercised-mdx mouse model of muscular dystrophy. Pharmacol Res. 2013 Jun;72:9-24. [3]. Blanqué R, et al. Characterization of GLPG0492, a selective androgen receptor modulator, in a mouse model of hindlimb immobilization. BMC Musculoskelet Disord. 2014 Sep 3;15:291.

Reseñas

Review for GLPG0492 R enantiomer

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for GLPG0492 R enantiomer

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.